I agree with you nothing has changed except for a negative seeking alpha article. If this is a coordinated attack on the SP this morning then they are not very successful. Down 3.96% on volume of 1.5 million shares as I'm writing this post.
The only debtor that UNS has is Orbimed. What UNS needs is a capital injection to continue operations. If the potential suitors believes the UNS has value and they will get a decent return then UNS will not have a problem getting more capital. They have come this far on roughly $300 Million in investor funds.
What no one knows is the value. The shorts don't and the longs don't and the traders don't. Orbimed has poked around the hood and now MS is doing the same thing. Orbimed before Sanofi WI and AbbVie thought UNS had viable business plan. Sadly outside of Orbimed, MS, and a potential suitor no one else has a clue and that is the problem with the SP.
Add to My Watchlist
What is My Watchlist?